article thumbnail

Opinion: Personalized medicine: We’re not there yet

STAT

When Francis Collins, then-director of the National Human Genome Research Institute, testified before Congress in 2003 about the significance of sequencing the human genome that year, he introduced personalized medicine as a new concept. ” Collins didn’t stop there.

Diabetes 337
article thumbnail

STAT+: Pharmalittle: More than 9 in 10 pharmacy techs report drug shortages; Yale and VA strike deal over ketamine patent royalties

STAT

Yale and the VA agreed in 2003 to share royalties on patents with inventors from both institutions. The techs who were queried identified chemotherapies; ADHD medicines; three drugs for weight loss and diabetes — Mounjaro, Ozempic, and Wegovy — and local anesthetics such as lidocaine as the top drugs experiencing shortages.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Towards a new understanding of cardiovascular risk in diabetes

pharmaphorum

A new post-hoc analysis from Novo Nordisk of their SUSTAIN 6 and PIONEER 6 studies into semaglutide is looking to help ‘individualise’ treatment for diabetes patients by better predicting their cardiovascular lifetime risk. The two studies included 6,480 people with type 2 diabetes with high cardiovascular risk aged between 50-90 years.

article thumbnail

OPDP Issues First Regulatory Action Letter of 2022

Eye on FDA

According to the letter, the agency noted first of all that the video that was part of the Instagram post stated that Trulicity could “lower A1C along with diet and exercise” but that the Medication Guide specifically states that the drug is used for people with type 2 diabetes.

article thumbnail

STAT+: Pharmalittle: Next big hope for Alzheimer’s might not help most Black patients; drugmakers ask Supreme Court to toss terrorism-support ruling

STAT

The business comprises more than 400 APIs used in drugs to treat everything from migraines to diabetes, and employs over 5,000 staff. Both are run by a husband-and-wife team that has received more than $17 million in NIH funding since 2003, according to the animal rights group.

article thumbnail

Insights+: An Analysis of the Growth of Biopharma Companies in the Last 20 Years (2003-2022)

PharmaShots

Through the inclusion of Pharmacia’s products along with a strong performance, Pfizer’s pharmaceutical and animal health revenue was boosted by 40% and 43% respectively In the year 2003, Johnson & Johnson generated a revenue of $41.9B which depicted a growth of 15.3% as compared to the previous year. from last year.

article thumbnail

Minority Health: The Importance of Patient Navigation and Access to Timely Care

Putting Patients First Blog

Similar patient experiences are supported by the 2003 Institute of Medicine’s (IOM) findings in Unequal Treatment that documented disparities in clinical interventions. Washington (DC): National Academies Press (US); 2003. 2 Unfortunately, health outcome indicators are still demonstrating inequities. PMID: 25032386. Lavizzo-Mourey, R.,